14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.70 $3.18 Thursday, 25th Apr 2024 GLYC stock ended at $1.71. This is 7.82% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.81% from a day low at $1.70 to a day high of $1.81.
90 days $1.70 $3.50
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Mar 20, 2024 $2.96 $3.10 $2.88 $3.05 627 502
Mar 19, 2024 $2.78 $3.02 $2.77 $2.93 430 814
Mar 18, 2024 $2.61 $2.87 $2.58 $2.80 468 185
Mar 15, 2024 $2.64 $2.69 $2.54 $2.56 242 121
Mar 14, 2024 $2.58 $2.68 $2.51 $2.61 177 965
Mar 13, 2024 $2.61 $2.75 $2.50 $2.55 423 490
Mar 12, 2024 $2.52 $2.71 $2.51 $2.62 323 398
Mar 11, 2024 $2.71 $2.87 $2.52 $2.56 262 641
Mar 08, 2024 $2.84 $2.95 $2.69 $2.73 418 150
Mar 07, 2024 $2.92 $2.99 $2.75 $2.80 331 797
Mar 06, 2024 $2.96 $3.03 $2.86 $2.90 254 566
Mar 05, 2024 $3.05 $3.05 $2.84 $2.90 167 253
Mar 04, 2024 $3.05 $3.08 $2.98 $3.04 196 293
Mar 01, 2024 $2.87 $3.07 $2.87 $3.01 215 019
Feb 29, 2024 $2.91 $3.06 $2.86 $2.89 191 213
Feb 28, 2024 $3.01 $3.08 $2.86 $2.87 234 175
Feb 27, 2024 $3.09 $3.09 $2.98 $3.02 192 987
Feb 26, 2024 $2.87 $3.11 $2.84 $3.06 248 362
Feb 23, 2024 $2.89 $2.97 $2.81 $2.90 241 792
Feb 22, 2024 $3.03 $3.07 $2.90 $2.93 248 747
Feb 21, 2024 $3.24 $3.25 $2.98 $2.99 316 424
Feb 20, 2024 $3.20 $3.36 $3.12 $3.33 379 833
Feb 16, 2024 $3.09 $3.22 $2.99 $3.22 321 716
Feb 15, 2024 $3.10 $3.15 $2.97 $3.09 201 640
Feb 14, 2024 $3.11 $3.15 $3.02 $3.08 168 549
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT